
MINNEAPOLIS, Oct. 23 (UPI) -- A U.S. study has determined why episodic treatment of the human immunodeficiency virus and AIDS with anti-retroviral drugs increases the overall risk of death.
James Neaton of the University of Minnesota and colleagues said it was known intermittent HIV/AIDS treatment was tied to inflammation and blood-clotting when compared with continuous antiretroviral treatment, or ART. But the reasons for that were unknown.
Neaton and colleagues have discovered higher levels of certain markers of inflammation and blood-clotting are strongly associated with intermittent ART and with a higher risk of death from non-AIDS diseases.
The scientists said they determined people who began the study with relatively higher levels of the biomarkers interleukin-6 and D-dimer were at greater risk of death than other study participants.
The new research appears in the journal PLoS Medicine.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, May 31 (UPI) --
The U.S. House Thursday rejected a bill that would outlaw abortions based on gender, with abortion opponents promising to make the vote an election issue.
|
NEW YORK, May 31 (UPI) --
Actor Michael McKean, who was hit by a car last week while walking in New York, says he has been discharged from St. Luke's Hospital.
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
CLEVELAND, May 31 (UPI) --
Cleveland prosecutors have dropped their case against a man who was ticketed for littering when he dropped a dollar he was attempting to give a disabled person.
|
| Stories | Photos | People | Comments |
View Caption